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1. Introduction
The relationship of visceral 
obesity with the development of 
cardiovascular disease, type 2 
diabetes mellitus (DM), as well 
as the impact of obesity and 
excess body weight (EBW) on 
quality and life expectancy, 
determine the relevance of the 
study of this problem [1]. It is 
well known that adipose tissue 
regulates glucose homeostasis 
not through its absorption, but 
indirectly, by regulation lipid 
homeostasis. Disruption of the 
balance of lipid metabolism can 
lead to systemic dysregulation 
of carbohydrate metabolism and 
the formation of insulin resis-
tance [2].
It is known that changes in 
the size of the intimo-medial 
segment of the common carotid 
artery acts as an early marker 
of the systemic atherosclerotic 
process [3]. In the case of an 
increase in the thickness of the 
indicator, there is an increase in 
the risk of atherosclerotic plaque 
formation several times over the 
next few years [4]. Thickening of 
the intima-media is associated 
with other risk factors for car-
diovascular disease (myocardial 
infarction, stroke, sudden death, 
smoking, dyslipidemia, hyper-
tension, etc.) [5]. Several studies 
have shown the association of 
intima-media thickening with 
the development of metabolic 
syndrome and DM [6]. There-
fore, the study of these struc-
tural characteristics in patients 
with DM in combination with 
EBW and obesity is an extreme-
ly important issue.
The aim: to assess the me-
tabolism of omentin-1 and to 
study the pathophysiological re-
lationship between its level and 
the severity of lesions of the in-
timo-medial segment of the ca-
rotid arteries in type 2 diabetes 
mellitus in combination with 
EBW and obesity.
2. Materials and methods
The work is a fragment of the research of the Department 
of Therapy, Clinical Pharmacology and Endocrinology of State 
Institution “Zaporozhye Medical Academy of Postgraduate 
Education of the Ministry of Health of Ukraine” – “The course 
of hypertension in combination with general diseases of the 
lungs and joints as a manifestation of comorbidity: traditional 
and additional risk factors”. ВН.Р. 03.23.03–15, No. state. reg-
istration 0115U000658. Totally 
98 people with DM were exam-
ined, who were inpatient treat-
ment in the KI “RK Endocrine 
Dispensary” ZRC in 2017–2020. 
Among the surveyed, the first 
group consisted of 64 people (34 
women and 30 men) with EBW 
and obesity (body mass index 
>25 kg/m2), average age 56.3± 
±10.23 years, the duration of DM 
was on average 7.47±5.07 years 
(with a run-up from the first 
identified to 28 years). The sec-
ond group consisted of 34 people 
(19 women and 15 men) with 
normal body weight (body mass 
index ≤25 kg/m2), the average 
age was 55.6±11.92 years, the du-
ration of DM was 6.5±5.70 years 
(with a run-up from the first 
identified to 22 years). As a con-
trol, a group of 28 apparently 
healthy individuals was exam-
ined, which was comparable to 
the first and second groups in 
terms of gender and age.
Authors confirm that the ap-
propriate ethics review and in-
formed consent welfare protocols 
have been followed and conduct-
ed their research in accordance 
with the World Medical Associa-
tion Declaration of Helsinki. The 
study protocol was approved by 
the Local Ethics Committee for 
all participants. Informed con-
sent was obtained from all pa-
tients included in the study.
The concentration of omen-
tin-1 was investigated by ELISA by 
solid-phase enzyme-linked im- 
munosorbent assay using com-
mercial test systems and a kit 
from Bender MedSystems GmbH 
(Austria) according to the in-
structions in vitro. Ultrasound 
of the carotid arteries was per-
formed in the lying position of 
the patient on the device My-
Lab50X with a linear sensor of 
7 MHz with a slight deviation 
of the patient’s head in the op-
posite direction. Measurements 
were performed in B-mode in the 
longitudinal section along the 
distal wall of the carotid arteries at a distance of 1.0 to 1.5 cm 
proximal to the bifurcation of the common carotid artery.
Data are presented as mean and standard error of the mean. 
Correlation analysis between groups of independent samples 
using the Spearman correlation coefficient was used to deter-
mine the direction and nature of the relationship. The statistical 
significance of intergroup differences was assessed using the 
Mann-Whitney method. Statistical analysis was performed 
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using the program “Statistica 6.1” (StatSoft Inc., USA, se- 
rial No. RGXR412D674002FWC7). For all types of analysis, dif-
ferences at a significance level of less than 0.05 were considered 
statistically significant.
3. Results
The study determined the concentration of omentin-1 in the 
subjects depending on the presence of EBW. The results show 
that patients of the first group with type 2 DM and obesity had 
the lowest levels of omentin-1 – 8.08 ng/ml compared to patients 
of the second group who were not obese (the difference was 
127.48 %, p<0.05) and especially for relatively healthy people in 
the control group – 21.08 ng/ml. Overweight and obesity led to 
a significant decrease in serum omentin-1 in patients of the first 
group, which, in turn, leads to increased insulin resistance and 
worsening of type 2 DM, as well as activation of pathogenetic 
chain mechanisms of cardiovascular damage and a number 
of concomitant metabolic changes. In addition, a decrease in 
omentin-1 values leads to increased levels of triglycerides and 
very-low-density lipoprotein cholesterol. Decreased omentin-1 
levels are also accompanied by a decrease in blood levels of adi-
ponectin and high-density lipoprotein cholesterol.
Next, we studied the concentration of omentin-1 metabo-
lism in the subjects depending on the degree of compensation 
for type 2 DM in patients of different groups. Decompensated 
type 2 DM in patients with EBW with HbA1c values ≥8 % was 
ref lected in a steady decrease in omentin-1 levels (7.73 ng/ml) 
in patients of this cohort – 28.29 % less than patients with 
diabetes and EBW in the compensated course of the disease 
(10.78 ng/ml). In relatively healthy subjects of the control 
group, omentin-1 was 48.86 % higher as patients the first 
group with compensated DM, and 63.33 % higher than pa-
tients with HbA1c≥8 % (p<0.05), and mean was 21 ng/ml. In 
the second group of patients with type 2 DM without EBW, the 
peculiarities of diabetes and the quality of glycemic control 
did not significantly affect the level of omentin-1. With good 
glycemic control and HbA1c<8 % without EBW omentin-1 
was 13.66 % higher (19.55 ng/ml) than with type 2 DM decom-
pensation without EBW and HbA1c≥8 % (16.88 ng/ml), and 
compared to the control group was lower by 7.26 and 19.92 %, 
respectively (mean of the control group was 21.08 ng/ml).
The increase in the duration of type 2 DM for more than 
5 years in both obese and non-obese patients was manifested by 
a decrease in omentin-1 levels by 39.24 and 25.95 %, respectively 
(p<0.05), and amounted to 4.94 and 14.15 ng/ml. In the presence 
of patients with type 2 DM lasting up to 5 years, with EBW and 
obesity, omentin-1 was determined at the level of 8.13 ng/ml 
(difference with the control group of 61.43 %), in the absence 
of EBW and obesity – 19.11 ng/ml, it was close to the values of 
healthy people – 21.08 ng/ml (difference 9.35 %) (p<0.05). In 
patients with type 2 DM lasting more than 5 years, with EBW 
and obesity omentin-1 was lower relative to the control group 
by 76.57 %, and in the absence of EBW and obesity – by 32.87 % 
(p<0.05). That is, with increasing duration of type 2 DM there is 
a gradual decrease in omentin-1 values in patients, especially in 
the group of patients with obesity and EBW.
In our work, we also determined the thickness of the com-
plex of the intima-media segment (IMT) of the brachiocephalic 
arteries in the subjects depending on different characteristics. 
At persons of the 1st group the indicator was the maximum 
both from the right (1.18 mm), and the left side (1.15 mm) in 
comparison with indicators of persons of the 2nd group – 0.91 
and 0.99 mm, more by 16.10 % (p<0.05) and 20, 87 % (p<0.05), 
respectively. The difference between the 1st and control groups 
was 38.82 % (p<0.05) and 27.78 % (p<0.05) on the right and left 
side, respectively. This indicator in the 2nd group on the left side 
was comparable to the control group (difference 1.11 %), and on 
the right side was 16.47 % (p<0.05) more compared to almost 
healthy individuals.
The state of carbohydrate metabolism compensation in 
individuals with type 2 DM in combination with EBW and 
obesity had a significant effect on IMT. Thus, in the 1st group, 
the IMT index under the condition of HbA1c≥8 % on the left 
side was 15.69 % (p<0.05) more (1.18 mm) than with effec-
tive compensation carbohydrate metabolism and HbA1c<8 % 
(1.02 mm), on the right side the difference was also significant 
and amounted to 15.38 % (p<0.05) at IMT values of 1.04 mm 
with HbA1c<8 % and 1.2 mm with HbA1c≥8 % (p<0.05). In 
group 2, in patients with different levels of glycosylated hemo-
globin, the value of IMT on both sides was comparable without 
statistically significant difference. Thus, on the left side the 
IMT indicator differed by 5.26 % in favor of the group with 
HbA1c <8 %, and on the right side – by 2.06 % in favor of the 
group with decompensation of DM – HbA1c ≥ 8 %. IMT on the 
left side in patients with HbA1c <8 % and HbA1c ≥ 8 % was 5.56 
and 1.12 % higher compared to the control group (p<0.05), and 
on the right side – by 14.12 and 16.47 %, respectively (p <0.05).
In the 1st group, the values of IMT on the right side were 
higher by 15.18 % (p<0.05) with a duration of DM for more 
than 5 years (1.29 mm) than with less history of the disease 
(1.12 mm), on the left side the corresponding difference was 
17.59 % (p<0.05), the value of IMT in patients with obesity 
and DM up to 5 years left was 1.08 mm, more than 5 years – 
1.27 mm. Regarding the control group, IMT was higher on 
the left side by 20.0 and 41.11 % (p <0.05) in patients of the 1st 
group up to 5 years and more than 5 years of type 2 DM, and 
on the right side – by 31.76 and 51.76 %, respectively (p<0.05). 
In the 2nd group, a significant difference in the values of IMT 
was determined by the case, amounting to 8.33 % (p<0.05) 
between persons with a disease duration of less than 5 years 
(0.96 mm) and more than this term (1.04 mm). On the left 
side, the corresponding difference was 10.34 % (p<0.05), the 
value of IMT in patients without obesity and DM up to 5 years 
of duration on the left side was 0.87 mm, more than 5 years – 
0.96 mm. Compared with the control group, IMT was lower on 
the left by 3.33 % and higher by 6.67 % in patients of group 2 
under 5 years and more than 5 years of type 2 DM, and on the 
right – higher by 12.94 and 22.35 % respectively (p<0.05).
In the presence of chronic diabetic complications in persons 
of the 1st group, the IMT index on the right side was 1.29 mm, 
on the left – 1.26 mm. In patients without DM complications 
IMT on the right was 1.16 mm, on the left – 1.14 mm. The dif-
ference in the indicators of IMT on the left side in patients of 
the 1st group with complications compared to patients without 
complications was significant and amounted to 10.5 % (p<0.05), 
on the right side – 11.21 % (p<0.05). Regarding the IMT control 
group, patients of the 1st group were statistically significantly 
higher on the left side by 26.67 and 40.00 % (p<0.05) com-
pared with the group without and with complications, and on 
the right side by 36.47 and 51.76 % (p<0.05), respectively. In 
group 2, the average IMT in people without and with chronic 
diabetic complications was comparable on both the right and 
left side, with an intergroup difference of 2.02 and 6.74 %, re-
spectively, on the right and left side. Regarding the IMT control 
group, the patients of the 2nd group had a difference on the left 
side by -1.11 and 5.56 % compared with the group without and 
with complications, and on the right side – by 16.47 and 18.82 % 
(p<0.05) respectively within the statistical significance.
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In order to assess not only the relationship, but also its 
focus and closeness, a correlation analysis by Spearman and 
regression analysis was performed. Evaluation of the correlation 
matrix showed the presence of a positive rather strong negative 
connection between the IMT (especially the right carotid ar-
tery) and the level of blood omentin-1 (Spearman Rank Order 
Correlations Rs=–0.55; p=0.002).
When constructing a functional relationship between IMT-
right/IMT-left and serum omentin-1 index, according to the 
results of regression analysis and scattering diagram study, it 
should be noted that the approximation error and the value of 
the residual variance show high accuracy of the obtained model. 
Thus, the problem of regression analysis can be considered solved 
for IMT-right (R=0.49, R2=0.24, normalized R2=0.22 at F=10.59, 
standard error 0.15, p<0.01). The recorded, gradually regressive 
parabola, interdependence shows that more than half of the total 
variance of the IMT-right trait may be associated with a change 
in the expression of omentin-1 (as a sign of impaired metabolism 
of adipose tissue hormones), with the largest increase in function 
observed in the range from 5 to 13, where in the vast majority 
of cases (almost 85 %) there was a structural and functional 
remodeling of the arteries and there are atherosclerotic signs of 
damage to the common carotid artery (IMT more than 1 mm). 
The obtained data indicate a statistically significant associative 
relationship between the dynamics of the generally accepted pre-
dictor of cardiovascular risk IMT with the degree of expression of 
adipose tissue hormone in patients with type 2 DM in combina-
tion with EBW or obesity. The largest number of individuals with 
omentin-1 levels from 5–10 ng/ml had significant disorders of the 
vascular wall (IMT from 1.0 to 1.2 mm).
4. Discussion
It is now well known that omentin-1 is an important adi-
pokine secreted by visceral adipose tissue. Evidence has shown 
that compared to EBW and obesity, omentin-1 has a more 
important effect on the prognosis of DM. Omentin-1 shows 
its effects as endocrine, paracrine and autocrine regulation [7]. 
These mechanisms suggest that altered omentin-1 secretion 
may disrupt glucose homeostasis in the body and subsequently 
contribute to the development of DM. It was found that exercise 
can increase serum omentin-1 in type 2 DM, while in other 
studies, metformin treatment could reduce serum omentin-1 in 
type 2 DM [8]. Obviously, aerobic exercise can be used to in-
crease omentin-1 levels in patients with diabetes, while drug 
interventions have an inhibitory effect. Some studies have re-
ported a decrease in omentin-1 levels in prediabetes [5]. A possi-
ble explanation for this phenomenon is that because omentin-1 
may increase insulin sensitivity, its decrease may cause impaired 
glucose homeostasis in patients with prediabetes. In clinical 
trials, circulating omentin-1 concentrations were reduced in 
obese/diabetic individuals. In obesity, the concentration of 
omentin-1 decreased in plasma and adipose tissue. In addition, 
it was found that the concentration of omentin-1 was positively 
correlated with high-density lipoprotein and adiponectin and, 
conversely, negatively correlated with body mass index and 
insulin resistance [9].
IMT is an important marker of atherosclerotic vascular 
disease worldwide. The method is simple, non-invasive and 
is performed using ultrasound of the arteries in B-mode, and 
therefore is used quite often in the diagnostic process. IMT 
is also a reliable predictor of future cerebral and cardiovas-
cular events. Regression of increased carotid artery IMT due 
to the positive effects of hypolipidemic and antihypertensive 
drugs has been reported. Despite the strong association 
between elevated IMT arteries and cardiovascular disease, 
the question of whether IMT arteries should be measured to 
detect subclinical progression of atherosclerosis in clinical 
practice remains unclear [10]. Researchers should consider 
other methodological aspects, such as determining the pa-
rameters and location of plaques, choosing the measurement 
site on the artery, and estimating the maximum or minimum 
IMT. Therefore, ultrasound examination of the artery is an 
important tool for assessing cardiovascular risk in a clinical 
setting.
Study limitations. The findings of this study have to be 
seen in light of some limitations. The first is the lack of pre-
vious research studies on the topic and the second limitation 
concerns the presence of the individual variability of the 
complex «intima – media carotids» in the same patient from 
different sides.
Prospects for further research. Prospects for further re-
search are to study the dynamics of serum omentin-1 levels in 
patients with metabolic syndrome during therapy with SGLT2 
inhibitors.
5. Conclusions
Obtained data indicate a statistically significant asso-
ciative relationship between the dynamics of the generally 
recognized predictor of cardiovascular risk, IMT, with the 
degree of impaired expression of the adipose tissue hormone 
omentin-1 in these patients. The thickness of the complex of 
the intima-media segment (intima-media thickness (IMT)) 
of the brachiocephalic arteries in the examined individuals 
was greater in the presence of EBW by 16.10 % (p<0.05) and 
20.87 % (p<0.05), respectively, on the right and left side. 
Depending on the degree of compensation for type 2 DM in 
obese patients, the thickness of the intima-media segment of 
the brachiocephalic arteries in the examined individuals had 
the following difference: with HbA1c≥8 % on the left side it 
was 15.69 % (p<0.05) more than HbA1c<8 %; on the right side 
the difference was also significant and amounted to 15.38 % 
(p<0.05). The thickness of the intima-media complex of the ca-
rotid arteries in the examined individuals with EBW increased 
with the duration of type 2 DM over 5 years by 17.59 and 
15.18 % (p<0.05) on the left and right side, respectively. The 
difference IMT indices on the left side in patients of group 1 
with obesity, type 2 DM and complications compare to pa-
tients without complications was significant and amounted to 
10.5 % (p<0.05), on the right side – 11.21 % (p<0.05).
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